RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
Primer ensayo clinico para COVID-19. Uso de Lopinavir/Ritonavir no mejora mortalidad y un 13% debe suspender el tto por efectos adversos. https://t.co/GEwr6VfUCL
RT @mrjohelpadilla: Una opción menos para paliar el daño del virus #SARSCoV2
RT @MaldonadoFabien: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/Ld7gWCeh4q
RT @Btk_Syk: https://t.co/sjTaWdYDsJ Ettttt.... Ça marche pas...
😞
RT @DrJeanneM: Just out today #COVID19 #Kaletra #treatment shows no benefit A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Seve…
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. https
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @orvizconv: Ensayo clínico: 199 pacientes con #COVID19 grave. No hubo diferencias significativas entre tratamiento de soporte estándar f…
RT @KevinKQinMD: “Treatment with lopinavir–ritonavir was not associated with a difference from standard care in the time to clinical improv…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @ABsteward: RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observe…
Badanie z wykorzystaniem połączenia lopinaviru z ritonavirem nie dało pozytywnych efektów w przypadku #COVID19
RCT 200 pts with severe #COVID19 published @NEJM In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir "Kaletra" treatment beyond standard care. #COVID19 #idtwitter #COVID19RX @mfkuepp @DrToddLee https://t.co
RT @Ted_Melnick: Disappointing results for Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 in today’s @NEJM http…
RT @bealelab: @tulunsokit @rabpeel @NephJC Trial has just reported no benefit of Lopinavir/Ritonavir in NEJM. #nephjc https://t.co/CQZM79xh…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
1/ Lopinavir400mg -Ritonavir 100mg for #COVID19 - Combined 1ary outcome: improvement or hospital discharge - Sample size 200, 1:1 randomization, open-label - No difference in the 1ary outcome was observed - 28d mortality similar too. Few comments: https
Heroic effort to do an RCT in Wuhan. Shame it doesn’t work but does show that we need to think hard about using experimental drugs without much clinical data
RT @infecciosasryc: Artículo relevante en #CoVID19: https://t.co/R3t5DqStiC No se observa beneficio asociado al uso de lopinavir/r (14 días…
RT @DrJeanneM: Just out today #COVID19 #Kaletra #treatment shows no benefit A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Seve…
Not that there were high hopes... https://t.co/DLrSoLCedP
RT @CarlosdelRio7: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | No benefit observed in #COVID19 in these pa…
RT @orvizconv: Ensayo clínico: 199 pacientes con #COVID19 grave. No hubo diferencias significativas entre tratamiento de soporte estándar f…
Negative results are also important to know at this point. These drugs did not help. @ScottGottliebMD @CDCgov @SteveFDA @EmoryMedicine @emoryhealthcare @NorthsideHosp @GaDPH
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/V7BTQxP7Ch
Disappointing, but perhaps not unsurprising. Other irons in the fire, so fingers crossed on one or more of those...
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @DrJeanneM: Just out today #COVID19 #Kaletra #treatment shows no benefit A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Seve…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
@DrEricDing @DrDenaGrayson no benefit seen with HIV drug Kaletra in NEJM published study. https://t.co/hLvOJQHp9K
RT @NatRevDrugDisc: A clinical trial reported in @NEJM has observed no benefit for treatment with the HIV protease inhibitors lopinavir–rit…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @Ted_Melnick: Disappointing results for Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 in today’s @NEJM http…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @DomingoPascualF: lopinavir–ritonavir sin beneficio aparente en estudio pequeño de 200 pacientes frente a #COVID19 en @NEJM https://t.co…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @DrJeanneM: Just out today #COVID19 #Kaletra #treatment shows no benefit A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Seve…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @AndyBiotech: Here comes the data from first randomized trial for #COVID19 Unfortunately no benefit was observed with $ABBV lopinavir–…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
Please leave LPV/r and DRV/r(c) alone! Preserve the supply for people with HIV. They are beginning to be harder to come by outpatient.
RT @vmcorman: "In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond stand…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @Aiims1742: Well there goes Kaletra for severe #COVID19. https://t.co/5JMdN9ez9f
“Treatment with lopinavir–ritonavir was not associated with a difference from standard care in the time to clinical improvement... In a modified intention-to-treat analysis... led to a median time to clinical improvement that was shorter by 1 day...” http
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
RT @vmcorman: "In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond stand…
RT @drmiguelmarcos: ▶️Primer ensayo clínico en #coronavirus #COVID19 🟢Lopinavir/ritonavir vs. placebo ❌No hay diferencias significativas…
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/iP32hoZc6b
RT @SICUPharmD: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 did not show any benefit I. This small study @S…
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
RT @donni__69: Un ensayo chino con lopinavir-ritonavir no consigue demostrar claro beneficio en pacientes con #COVID19. La mortalidad y est…
RT @BogochIsaac: Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patient…
Ensayo clínico: 199 pacientes con #COVID19 grave. No hubo diferencias significativas entre tratamiento de soporte estándar frente a añadir lopinavir/ritonavir
RT @AdrienContejean: Pas de bénéfice clinique/mortalité dans cet essai randomisé A Trial of Lopinavir–Ritonavir in Adults Hospitalized wit…
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @NatRevDrugDisc: A clinical trial reported in @NEJM has observed no benefit for treatment with the HIV protease inhibitors lopinavir–rit…
RT @gpollara: Disappointing news 😔 Lopinavir/ritonavir (Kaletra) not beneficial in severe #COVID19 disease. @NEJM https://t.co/rUkQpPk8af…
Disappointing results from a study, looking at Lopinavir–Ritonavir for #COVID19 infection. "In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care." https://t.co/ukuOOIrS04
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @FranciscoMarty_: #Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra. How impo…
RT @KamiMasahiro: もうRCTの結果が出ています。 https://t.co/dbE8VREUo7
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/pGQfTfHqtl NO BENEFIT AS PER THE STUDY #coronavirus #COVID19 @NEJM
RT @DrMCecconi: best evidence for COVID-19 supportive care, do the basic right and Primum Non Nocere. Way to go for research even during a…
RT @boback: A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 @nejm https://t.co/G1cSCEscnP
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://t.co/NjNrxOSOnM